PBM
Psyence Biomedical Ltd.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Last price
4.30
▲ 0.37 (9.31%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
4.04
Prev close
3.93
Day high
4.49
Day low
3.95
Volume
103.39K
Market cap
—
P/E (TTM)
—
52W range
1.92 – 216.41
Day trading desk
Gap from prior close
+2.80%
Prior close 3.93
VWAP
4.19
+2.48% from price
Relative volume
1.12×
Normal
Session range
14.54%
3.92 – 4.49
Position in range
66%
Mid range
ATR (14D)
0.38
8.91% of price
Prior day high
4.02
PDH
Prior day low
3.73
PDL
Bid / ask spread
—
Quote not published
Session volume
100.54K
Avg 90.13K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+24.43%
+25.8%
1M
+53.55%
+49.8%
3M
+6.65%
+3.6%
6M
+73.20%
+62.1%
YTD
-85.28%
-97.6%
1Y
-96.64%
-116.6%
3Y
-100.00%
-174.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PBM open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
113.28K
Total on file
Fundamentals
Market cap—
Enterprise value$9.07M
Revenue (TTM)—
Gross profit—
EBITDA$-6.23M
Net income$-6.94M
EPS (TTM)$-12.56
Free cash flow$-4.96M
Total cash$7.44M
Total debt$0
Book value / share—
Shares outstanding—
Float2.61M
Short % of float1.40%
Dividend yield—
Beta (5Y)1.67
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA-1.46
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-58.62%
Return on assets-31.33%
Debt / equity—
Current ratio14.62
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — | — |
| Operating revenue | $0 | $0 | $0 | $0 | — | — |
| Research & development | $1.47M | $342.17K | $954.59K | $1.61M | — | +328.6% |
| Selling, general & admin | $4.77M | $3.32M | $1.80M | $1.63M | — | +43.7% |
| Total operating expense | $5.95M | $3.66M | $43.35M | $3.23M | — | +62.3% |
| Operating income | -$5.95M | -$3.66M | -$43.35M | -$3.23M | — | -62.3% |
| Net interest income | $253.85K | $86.52K | -$50.81K | $1.55K | — | +193.4% |
| Pre-tax income | -$6.94M | $1.01M | -$51.16M | -$3.21M | — | -785.6% |
| Net income | -$6.94M | $1.01M | -$51.16M | -$3.21M | — | -785.6% |
| Net income to common | -$6.94M | $1.01M | -$51.16M | -$3.21M | — | -785.6% |
| Basic EPS | — | 32.76 | -14,274.29 | -940.02 | -544.78 | — |
| Diluted EPS | — | 32.76 | -14,274.29 | -940.02 | -544.78 | — |
| EBIT | -$6.93M | $1.02M | -$51.11M | -$3.21M | — | -778.4% |
| EBITDA | -$6.92M | $1.03M | -$51.11M | -$3.21M | — | -775.1% |
| Basic shares | — | 30.89K | 3.58K | 3.41K | 3.41K | — |
| Diluted shares | — | 30.89K | 3.58K | 3.41K | 3.41K | — |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $7.44M | $6.14M | $733.19K | $1.33M | +21.3% |
| Cash & short-term investments | $7.44M | $6.14M | $733.19K | $1.33M | +21.3% |
| Total current assets | $9.11M | $6.56M | $1.13M | $1.59M | +38.9% |
| Property, plant & equipment | $6.06K | $11.10K | $5.49K | $0 | -45.4% |
| Total assets | $17.57M | $7.32M | $1.13M | $1.59M | +140.1% |
| Total current liabilities | $623.19K | $594.37K | $12.10M | $1.79M | +4.8% |
| Current debt | — | — | $10.45M | — | — |
| Total debt | — | — | $10.45M | — | — |
| Total liabilities | $623.19K | $594.37K | $12.10M | $1.79M | +4.8% |
| Retained earnings | -$63.38M | -$56.45M | -$57.46M | -$6.30M | -12.3% |
| Shareholder equity | $16.94M | $6.72M | -$10.97M | -$200.44K | +152.1% |
| Working capital | $8.49M | $5.97M | -$10.98M | -$200.44K | +42.3% |
| Net tangible assets | $16.94M | $6.72M | -$10.97M | -$200.44K | +152.1% |
| Shares issued | 2.29M | 90.88K | 3.58K | 3.41K | +2,423.3% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | -$6.94M | $1.01M | -$51.16M | -$3.21M | -785.6% |
| Depreciation & amortisation | $5.27K | $4.27K | $240 | $0 | +23.4% |
| Stock-based compensation | $155.34K | $0 | $317.88K | $221.29K | — |
| Change in working capital | -$1.22M | -$386.20K | -$1.17M | $1.48M | -214.9% |
| Operating cash flow | -$8.14M | -$3.73M | -$2.95M | -$1.59M | -118.1% |
| Capital expenditure | -$500.23K | -$9.88K | -$5.73K | — | -4,964.6% |
| Investing cash flow | -$4.51M | -$16.23K | -$5.73K | $0 | -27,697.0% |
| Financing cash flow | $13.96M | $9.15M | $2.35M | $1.17M | +52.6% |
| Free cash flow | -$8.64M | -$3.74M | -$2.95M | -$1.59M | -130.8% |
| End cash position | $7.44M | $6.14M | $733.19K | $1.33M | +21.3% |
| Line item | 2025-09-30 | YoY |
|---|---|---|
| Total revenue | $0 | |
| Operating revenue | $0 | |
| Research & development | $357.44K | |
| Selling, general & admin | $1.15M | |
| Total operating expense | $1.51M | |
| Operating income | -$1.51M | |
| Net interest income | $70.06K | |
| Pre-tax income | -$753.25K | |
| Net income | -$753.25K | |
| Net income to common | -$753.25K | |
| Basic EPS | -3.19 | |
| Diluted EPS | -3.19 | |
| EBIT | -$750.50K | |
| EBITDA | -$749.17K | |
| Basic shares | 237.04K | |
| Diluted shares | 237.04K |
| Line item | 2025-09-30 | YoY |
|---|---|---|
| Cash & equivalents | $7.15M | |
| Cash & short-term investments | $7.15M | |
| Total current assets | $7.63M | |
| Property, plant & equipment | $8.69K | |
| Total assets | $12.81M | |
| Total current liabilities | $943.07K | |
| Total liabilities | $943.07K | |
| Retained earnings | -$58.44M | |
| Shareholder equity | $11.87M | |
| Working capital | $6.69M | |
| Net tangible assets | $11.87M | |
| Shares issued | 299.53K |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders2.97%
Held by institutions9.72%
Institutions holding10
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
3.77
+13.92% from price
SMA 20
3.50
+23.70% from price
SMA 50
3.22
+34.52% from price
SMA 100
4.05
+6.08% from price
SMA 200
18.23
-76.25% from price
EMA 12
3.79
+13.39% from price
EMA 26
3.54
+21.28% from price
EMA 50
3.66
+17.48% from price
RSI (14)
65.7
Neutral
MACD (12,26,9)
0.25
Hist 0.10
ATR (14)
0.38
8.84% of price
Realised vol 30D
94.4%
Annualised
Bollinger upper
4.30
20, 2σ
Bollinger lower
2.70
20, 2σ
50 / 200 cross
Death
3.22 vs 18.23
Trend bias
Below 200
-76.25%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
3.10
More volatile than market
Correlation to SPY
0.21
Largely independent
Realised vol 30D
94.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-98.9%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.38
8.84% of price
Beta (reported)
1.67
5Y monthly, from filing
Short interest
Shares short
37.42K
Prior 36.01K
Change vs prior
+3.9%
Shorts adding
% of float
1.40%
Normal
% of shares out
0.98%
Against total outstanding
Days to cover
0.4
Liquid
Float
2.61M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split16:100
Split dateFeb 2, 2026
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-08-06
Periodic Financial Reports
20-F · 2026-06-22
Corporate Changes & Voting Matters
6-K · 2026-06-05
Corporate Changes & Voting Matters
6-K · 2026-04-23
Corporate Changes & Voting Matters
6-K · 2026-04-20
Corporate Changes & Voting Matters
6-K · 2026-04-17
Corporate Changes & Voting Matters
6-K · 2026-04-15
Corporate Changes & Voting Matters
6-K · 2026-03-02
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.